Logo image of TN8.DE

THERMO FISHER SCIENTIFIC INC (TN8.DE) Stock Fundamental Analysis

Europe - FRA:TN8 - US8835561023 - Common Stock

489.4 EUR
-8.5 (-1.71%)
Last: 11/18/2025, 7:00:00 PM
Fundamental Rating

4

Taking everything into account, TN8 scores 4 out of 10 in our fundamental rating. TN8 was compared to 18 industry peers in the Life Sciences Tools & Services industry. TN8 has only an average score on both its financial health and profitability. While showing a medium growth rate, TN8 is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

TN8 had positive earnings in the past year.
TN8 had a positive operating cash flow in the past year.
Each year in the past 5 years TN8 has been profitable.
Each year in the past 5 years TN8 had a positive operating cash flow.
TN8.DE Yearly Net Income VS EBIT VS OCF VS FCFTN8.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

1.2 Ratios

With a decent Return On Assets value of 6.38%, TN8 is doing good in the industry, outperforming 77.78% of the companies in the same industry.
TN8 has a Return On Equity of 12.88%. This is in the better half of the industry: TN8 outperforms 72.22% of its industry peers.
With a Return On Invested Capital value of 6.43%, TN8 perfoms like the industry average, outperforming 55.56% of the companies in the same industry.
TN8 had an Average Return On Invested Capital over the past 3 years of 6.66%. This is significantly below the industry average of 13.84%.
Industry RankSector Rank
ROA 6.38%
ROE 12.88%
ROIC 6.43%
ROA(3y)6.58%
ROA(5y)7.42%
ROE(3y)13.8%
ROE(5y)15.76%
ROIC(3y)6.66%
ROIC(5y)7.62%
TN8.DE Yearly ROA, ROE, ROICTN8.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

TN8's Profit Margin of 15.02% is fine compared to the rest of the industry. TN8 outperforms 77.78% of its industry peers.
TN8's Profit Margin has been stable in the last couple of years.
The Operating Margin of TN8 (18.40%) is better than 72.22% of its industry peers.
TN8's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 41.43%, TN8 is in the better half of the industry, outperforming 61.11% of the companies in the same industry.
TN8's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 18.4%
PM (TTM) 15.02%
GM 41.43%
OM growth 3Y-12.04%
OM growth 5Y1.61%
PM growth 3Y-9.15%
PM growth 5Y0.42%
GM growth 3Y-6.24%
GM growth 5Y-1.42%
TN8.DE Yearly Profit, Operating, Gross MarginsTN8.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

4

2. Health

2.1 Basic Checks

TN8 has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for TN8 has been reduced compared to 1 year ago.
TN8 has less shares outstanding than it did 5 years ago.
The debt/assets ratio for TN8 has been reduced compared to a year ago.
TN8.DE Yearly Shares OutstandingTN8.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
TN8.DE Yearly Total Debt VS Total AssetsTN8.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B

2.2 Solvency

TN8 has a debt to FCF ratio of 5.84. This is a neutral value as TN8 would need 5.84 years to pay back of all of its debts.
With a Debt to FCF ratio value of 5.84, TN8 perfoms like the industry average, outperforming 55.56% of the companies in the same industry.
TN8 has a Debt/Equity ratio of 0.62. This is a neutral value indicating TN8 is somewhat dependend on debt financing.
The Debt to Equity ratio of TN8 (0.62) is worse than 61.11% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF 5.84
Altman-Z N/A
ROIC/WACC0.66
WACC9.8%
TN8.DE Yearly LT Debt VS Equity VS FCFTN8.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

2.3 Liquidity

TN8 has a Current Ratio of 1.50. This is a normal value and indicates that TN8 is financially healthy and should not expect problems in meeting its short term obligations.
TN8's Current ratio of 1.50 is fine compared to the rest of the industry. TN8 outperforms 66.67% of its industry peers.
TN8 has a Quick Ratio of 1.11. This is a normal value and indicates that TN8 is financially healthy and should not expect problems in meeting its short term obligations.
TN8 has a better Quick ratio (1.11) than 61.11% of its industry peers.
Industry RankSector Rank
Current Ratio 1.5
Quick Ratio 1.11
TN8.DE Yearly Current Assets VS Current LiabilitesTN8.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

4

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 4.53% over the past year.
TN8 shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 12.12% yearly.
TN8 shows a small growth in Revenue. In the last year, the Revenue has grown by 3.22%.
TN8 shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.92% yearly.
EPS 1Y (TTM)4.53%
EPS 3Y-4.52%
EPS 5Y12.12%
EPS Q2Q%9.66%
Revenue 1Y (TTM)3.22%
Revenue growth 3Y3.03%
Revenue growth 5Y10.92%
Sales Q2Q%4.94%

3.2 Future

Based on estimates for the next years, TN8 will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.66% on average per year.
Based on estimates for the next years, TN8 will show a small growth in Revenue. The Revenue will grow by 4.65% on average per year.
EPS Next Y5.02%
EPS Next 2Y6.77%
EPS Next 3Y7.78%
EPS Next 5Y9.66%
Revenue Next Year3.49%
Revenue Next 2Y4.24%
Revenue Next 3Y4.65%
Revenue Next 5Y4.65%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
TN8.DE Yearly Revenue VS EstimatesTN8.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 10B 20B 30B 40B 50B
TN8.DE Yearly EPS VS EstimatesTN8.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 10 20 30

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 25.32, which means the current valuation is very expensive for TN8.
Based on the Price/Earnings ratio, TN8 is valued a bit cheaper than the industry average as 61.11% of the companies are valued more expensively.
TN8 is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 25.51, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 22.76, the valuation of TN8 can be described as rather expensive.
61.11% of the companies in the same industry are more expensive than TN8, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of TN8 to the average of the S&P500 Index (34.98), we can say TN8 is valued slightly cheaper.
Industry RankSector Rank
PE 25.32
Fwd PE 22.76
TN8.DE Price Earnings VS Forward Price EarningsTN8.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

61.11% of the companies in the same industry are cheaper than TN8, based on the Enterprise Value to EBITDA ratio.
The rest of the industry has a similar Price/Free Cash Flow ratio as TN8.
Industry RankSector Rank
P/FCF 35.06
EV/EBITDA 22.57
TN8.DE Per share dataTN8.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
TN8 has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)5.04
PEG (5Y)2.09
EPS Next 2Y6.77%
EPS Next 3Y7.78%

3

5. Dividend

5.1 Amount

With a yearly dividend of 0.30%, TN8 is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 0.74, TN8 is paying slightly less dividend.
With a Dividend Yield of 0.30, TN8 pays less dividend than the S&P500 average, which is at 2.44.
Industry RankSector Rank
Dividend Yield 0.3%

5.2 History

The dividend of TN8 is nicely growing with an annual growth rate of 15.42%!
Dividend Growth(5Y)15.42%
Div Incr Years4
Div Non Decr Years4
TN8.DE Yearly Dividends per shareTN8.DE Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

TN8 pays out 9.48% of its income as dividend. This is a sustainable payout ratio.
TN8's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP9.48%
EPS Next 2Y6.77%
EPS Next 3Y7.78%
TN8.DE Yearly Income VS Free CF VS DividendTN8.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B
TN8.DE Dividend Payout.TN8.DE Dividend Payout, showing the Payout Ratio.TN8.DE Dividend Payout.PayoutRetained Earnings

THERMO FISHER SCIENTIFIC INC

FRA:TN8 (11/18/2025, 7:00:00 PM)

489.4

-8.5 (-1.71%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)10-22 2025-10-22/bmo
Earnings (Next)01-28 2026-01-28/amc
Inst Owners91.65%
Inst Owner ChangeN/A
Ins Owners0.09%
Ins Owner ChangeN/A
Market Cap184.80B
Revenue(TTM)43.74B
Net Income(TTM)6.57B
Analysts80.63
Price Target541.83 (10.71%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.3%
Yearly Dividend1.3
Dividend Growth(5Y)15.42%
DP9.48%
Div Incr Years4
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)2.99%
Min EPS beat(2)1.61%
Max EPS beat(2)4.37%
EPS beat(4)3
Avg EPS beat(4)1.9%
Min EPS beat(4)-0.07%
Max EPS beat(4)4.37%
EPS beat(8)5
Avg EPS beat(8)2.24%
EPS beat(12)7
Avg EPS beat(12)1.19%
EPS beat(16)11
Avg EPS beat(16)4.2%
Revenue beat(2)2
Avg Revenue beat(2)0.79%
Min Revenue beat(2)0.62%
Max Revenue beat(2)0.95%
Revenue beat(4)4
Avg Revenue beat(4)0.47%
Min Revenue beat(4)0.04%
Max Revenue beat(4)0.95%
Revenue beat(8)6
Avg Revenue beat(8)0.12%
Revenue beat(12)7
Avg Revenue beat(12)0.36%
Revenue beat(16)11
Avg Revenue beat(16)2.75%
PT rev (1m)12.09%
PT rev (3m)12.05%
EPS NQ rev (1m)-1.14%
EPS NQ rev (3m)-1.21%
EPS NY rev (1m)0.96%
EPS NY rev (3m)1.79%
Revenue NQ rev (1m)1.28%
Revenue NQ rev (3m)1.51%
Revenue NY rev (1m)0.71%
Revenue NY rev (3m)0.97%
Valuation
Industry RankSector Rank
PE 25.32
Fwd PE 22.76
P/S 4.9
P/FCF 35.06
P/OCF 28
P/B 4.2
P/tB N/A
EV/EBITDA 22.57
EPS(TTM)19.33
EY3.95%
EPS(NY)21.5
Fwd EY4.39%
FCF(TTM)13.96
FCFY2.85%
OCF(TTM)17.48
OCFY3.57%
SpS99.93
BVpS116.59
TBVpS-33.14
PEG (NY)5.04
PEG (5Y)2.09
Graham Number225.18
Profitability
Industry RankSector Rank
ROA 6.38%
ROE 12.88%
ROCE 9.13%
ROIC 6.43%
ROICexc 6.7%
ROICexgc 29.73%
OM 18.4%
PM (TTM) 15.02%
GM 41.43%
FCFM 13.97%
ROA(3y)6.58%
ROA(5y)7.42%
ROE(3y)13.8%
ROE(5y)15.76%
ROIC(3y)6.66%
ROIC(5y)7.62%
ROICexc(3y)7.33%
ROICexc(5y)8.51%
ROICexgc(3y)36.42%
ROICexgc(5y)41.56%
ROCE(3y)9.48%
ROCE(5y)10.9%
ROICexgc growth 3Y-8.22%
ROICexgc growth 5Y1.35%
ROICexc growth 3Y-8.88%
ROICexc growth 5Y2.89%
OM growth 3Y-12.04%
OM growth 5Y1.61%
PM growth 3Y-9.15%
PM growth 5Y0.42%
GM growth 3Y-6.24%
GM growth 5Y-1.42%
F-Score8
Asset Turnover0.42
Health
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF 5.84
Debt/EBITDA 2.94
Cap/Depr 55.1%
Cap/Sales 3.52%
Interest Coverage 250
Cash Conversion 70.55%
Profit Quality 93%
Current Ratio 1.5
Quick Ratio 1.11
Altman-Z N/A
F-Score8
WACC9.8%
ROIC/WACC0.66
Cap/Depr(3y)51.6%
Cap/Depr(5y)63.11%
Cap/Sales(3y)3.9%
Cap/Sales(5y)4.54%
Profit Quality(3y)109.9%
Profit Quality(5y)104.9%
High Growth Momentum
Growth
EPS 1Y (TTM)4.53%
EPS 3Y-4.52%
EPS 5Y12.12%
EPS Q2Q%9.66%
EPS Next Y5.02%
EPS Next 2Y6.77%
EPS Next 3Y7.78%
EPS Next 5Y9.66%
Revenue 1Y (TTM)3.22%
Revenue growth 3Y3.03%
Revenue growth 5Y10.92%
Sales Q2Q%4.94%
Revenue Next Year3.49%
Revenue Next 2Y4.24%
Revenue Next 3Y4.65%
Revenue Next 5Y4.65%
EBIT growth 1Y8.68%
EBIT growth 3Y-9.38%
EBIT growth 5Y12.7%
EBIT Next Year13.53%
EBIT Next 3Y9.14%
EBIT Next 5Y9.93%
FCF growth 1Y-6.66%
FCF growth 3Y2.29%
FCF growth 5Y12.42%
OCF growth 1Y-6.36%
OCF growth 3Y-2.36%
OCF growth 5Y11.75%

THERMO FISHER SCIENTIFIC INC / TN8.DE FAQ

What is the fundamental rating for TN8 stock?

ChartMill assigns a fundamental rating of 4 / 10 to TN8.DE.


What is the valuation status of THERMO FISHER SCIENTIFIC INC (TN8.DE) stock?

ChartMill assigns a valuation rating of 3 / 10 to THERMO FISHER SCIENTIFIC INC (TN8.DE). This can be considered as Overvalued.


What is the profitability of TN8 stock?

THERMO FISHER SCIENTIFIC INC (TN8.DE) has a profitability rating of 6 / 10.


What are the PE and PB ratios of THERMO FISHER SCIENTIFIC INC (TN8.DE) stock?

The Price/Earnings (PE) ratio for THERMO FISHER SCIENTIFIC INC (TN8.DE) is 25.32 and the Price/Book (PB) ratio is 4.2.


How sustainable is the dividend of THERMO FISHER SCIENTIFIC INC (TN8.DE) stock?

The dividend rating of THERMO FISHER SCIENTIFIC INC (TN8.DE) is 3 / 10 and the dividend payout ratio is 9.48%.